Insider Transactions in Q1 2024 at Uni Qure N.V. (QURE)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2024
|
Matthew C Kapusta CEO, Managing Director |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+20.25%
|
-
|
|
Mar 01
2024
|
Walid Abi Saab Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
49,500
+29.78%
|
-
|
|
Mar 01
2024
|
Christian Klemt Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
49,500
+22.92%
|
-
|
|
Mar 01
2024
|
Pierre Caloz Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
33,000
+21.76%
|
-
|
|
Mar 01
2024
|
Jeannette Potts Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
49,500
+33.88%
|
-
|
|
Feb 26
2024
|
Pierre Caloz Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
9,455
-9.94%
|
$56,730
$6.47 P/Share
|
|
Feb 26
2024
|
Christian Klemt Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
15,906
-11.97%
|
$95,436
$6.38 P/Share
|
|
Feb 26
2024
|
Matthew C Kapusta CEO, Managing Director |
SELL
Open market or private sale
|
Direct |
27,904
-5.95%
|
$167,424
$6.35 P/Share
|